The senolytic drug mixture used in the research combined dasatinib, which promotes death of cancer cells, and quercetin, an antioxidant found in apples and other foods.
Notes on verification
Multiple independent academic, clinical trial, and peer-reviewed sources confirm both the dasatinib cancer-drug mechanism and quercetin's identity as a food-derived antioxidant, as well as their combined use as the D+Q senolytic regimen. [tier=gold indep_score=0.925 clusters=4 claim_tier=notable]
Sources
- Los senolíticos mejoran la salud y prolongan la vida: resultados del ... (seed:health_and_medicine)
- https://www.alzforum.org/therapeutics/dasatinib-quercetin (corroboration)
- https://cdn.clinicaltrials.gov/large-docs/24/NCT04063124/Prot_SAP_000.pdf (corroboration)
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10943199/ (corroboration)
- https://www.lifespan.io/road-maps/the-rejuvenation-roadmap/scripps-research-institute-dasatinib-and-quercetin (corroboration)